POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No105/2012
Date of issue:2012-10-30
Short name of the issuer
SOPHARMA AD
Subject
current report 105 uved za vlivane s BRS ENG
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
The Board of Directors of Sopharma AD (the “Company") hereby notifies that on 29 October 2012 was signed a merger agreement between Sopharma AD and Bulgarian Rose – Sevtopolis AD. The agreement settles both the technical process of the merger of Bulgarian Rose – Sevtopolis AD into Sopharma AD, as well as the ensuing consequences for the two companies. The contract and the accompanying documentation have been submitted to the Financial Supervision Commission.
Annexes
FileDescription
current report 105 uved za vlivane s BRS ENG.doccurrent report 105 uved za vlivane s BRS ENG
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2012-10-30Ognian DonevExecutive director